Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2023 - Critical Care
Download Issue
Share
Up Front
Publisher's Corner
Many National Healthcare Crises Accentuated by the Pandemic
By Patrick M. Schmidt
Features
Increased Demand for Specialty Pharmacies Due to Chronic Illnesses
By
Rachel Maier, MS
Long COVID: Shedding Light on Other Viral Infections
By
Jim Trageser
Myths & Facts: COVID-19
By
Ronale Tucker Rhodes, MS
The Burden of Lyme Disease
By
Meredith Whitmore
How FDA’s Risk Management Program Can Help Prevent or Lessen Future Drug Shortages
By
Amy Scanlin, MS
Addressing the Mental Health Crisis in Children
By
Trudie Mitschang
BioTrends Watch
Washington Report
HHS Releases New Reports on Positive Impact of Inflation Reduction Act on Prescription Drug Prices
Report Released on Chronic Diseases and Related Risk Factors
HHS Launches a National Biotechnology and Biomanufacturing Initiative
$2 Million Awarded to Study Risks and Benefits of Social Media on Youth
$11 Million Approved for Vaccine to Prevent Smallpox and Monkeypox
Reimbursement FAQs
The Inflation Reduction Act: A Radically Different Market Environment
Healthcare Management
How to Rectify the Growing Nursing Shortage
Industry News
First Once-Daily Oral Plaque Psoriasis Drug Approved by FDA
Study Finds IVIG Effective for Treating Dermatomyositis
Regen BioPharma Files Patent for mRNA Cancer Vaccine
First Malaria Vaccine Prequalified by WHO
TIL Therapy Found More Effective for Metastatic Melanoma Than Current Treatments
Study Finds Universal Influenza B Vaccine Induces Broad and Lasting Protection
FDA Approves Humira Biosimilar to Treat Autoimmune Disorders
Researchers Develop a New mRNA Vaccine to Treat Cancer
New Test Identifies Patients at Risk of Severe COVID-19
Study Finds Pfizer’s RSV Vaccine Effective in Preventing Illness in Older Adults
Experimental RSV Vaccine Shows Promise in Mice
WHO Publishes First Guidelines for Treating Ebola
BioFocus
Industry Insight
Message for At-Risk Adults: Flu Vaccination Will Reduce Your Risk of Cardiovascular Disease and Death
By Keith Berman, MPH, MBA
Patient Profile
Lyme Disease: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
Lyme Disease: A Physician’s Perspective
By Trudie Mitschang
BioSources
BioResearch
RNA Interference Therapeutic Reduces Hepatotoxic Mutant Z-AAT Levels in Patients with Alpha1-Antitrypsin Deficiency
Antibody Targeting Tissue Factor Pathway Inhibitor (TFPI) Sharply Reduces Bleeding Rate in Hemophilia A and B Patients